Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company ...
RedEffect Official on MSN
Armata engine development controversy reflects uncertainty around T-14 program
The engine designed for Russia’s T-14 Armata tank has faced delays, redesigns, and conflicting reports about performance.
Armata Pharmaceuticals (NYSE:ARMP) said its inhaled bacterial infection drug for lung disorder was well-tolerated with a treatment emergent adverse event (TEAE) profile similar to placebo in a phase ...
The Armata is a new-generation tank. It is a clean sheet design with a number of advanced features. It has little in common with the current T-90 and other older Soviet tanks. Actually it it the first ...
Summary: The T-14 Armata tank, unveiled in 2015, was intended to be a revolutionary advancement in armored warfare. -Featuring an unmanned turret, advanced armor, and a new 125mm smoothbore cannon, it ...
Summary and Key Points: Russia’s Soviet-era main battle tanks, such as the T-55s, T-62s, T-72s, T-80s, and T-90s, have been decimated by Western-supplied anti-tank weaponry during the Ukraine invasion ...
Investing.com -- Armata Pharmaceuticals Inc (NYSE American:ARMP) shares rose 3.1% in premarket trading Monday after the company announced that the U.S. Food and Drug Administration granted Qualified ...
LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on pathogen-specific ...
Intravenous use as a QIDP for adjunct treatment of complicated bacteremia caused by Staphylococcus aureus QIDP Designation provides for five years of market exclusivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results